Smoking Cessation Aids Market Global Analysis & Forecast 2028
The Smoking Cessation Aids market is expected to reach US$ 64,032.30 million by 2028 from US$ 23,413.08 million in 2021. The market is estimated to grow with a CAGR of 15.5% from 2021 to 2028.
Key factors that are driving the growth of this smoking cessation aids market are rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.
Market Insights
Rising addiction of tobacco smoking
Nicotine is a highly addictive substance found in tobacco plant. The smoking of tobacco is proven to be dangerous in all forms as it can lead to chronic health conditions, preventable diseases, deaths, and disabilities. According to the World Health Organization (WHO), smoking-related disorders result in about 435,000 deaths per year in the US, which equals to around 1 in 5 of the total deaths in the country. According to the Centers of Disease Control and Prevention (CDC), in 2018, nearly 40 million adults in the US smoked cigarettes. Moreover, about 4.7 million middle and high-school students used at least one tobacco product and around 1,600 young population below the age of 18 in the US smoked their first cigarettes. Every year, nearly half a million patients die due to illness caused by smoking. The US government spends ~US$ 225 billion for medical care to treat patients suffering from smoking-associated conditions in the US. Therefore, prevalence of tobacco smoking is high across various countries in the world.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Smoking Cessation Aids Market: Strategic Insights
Market Size Value in US$ 23,413.08 Million in 2021 Market Size Value by US$ 64,032.30 Million by 2028 Growth rate CAGR of 15.5% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Smoking Cessation Aids Market: Strategic Insights
| Market Size Value in | US$ 23,413.08 Million in 2021 |
| Market Size Value by | US$ 64,032.30 Million by 2028 |
| Growth rate | CAGR of 15.5% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The scenario is similar in various European and Asian countries. Greece, Bulgaria, France, and Croatia comprise the high tobacco consuming populations in Europe. According to the Institute of Health Metrics and Evaluation, smoking is a very common addiction in Europe as over 20% adults over the age of 15 smoke every day. Furthermore, according to the World Population Review, the highest smoking rates are found in Southeast Asia and Balkan in Europe. The WPR also suggests that in various South and Southeast Asian countries, the smoking rates tend to be high among men. For instance, in Indonesia, the smoking rate among males was 76.20% in 2018. Thus, the rising number of smoking populations across the world drives the growth of the global smoking cessation aids market.
Product-Based Insights
Based on product, the smoking cessation aids market is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. E-cigarettes are considered as a healthy alternative to tobacco cigarettes and is estimated to be the fastest growing segment over the forecast period. E-cigarettes are an effective alternative for reducing health conditions associated with tobacco, while nicotine replacement therapies work best for smoking cessation. E-cigarettes are a potential threat to tobacco-based cigarettes. In addition, Consumption of e-cigarettes are less harmful compared to the regular cigarettes, no smoke and no risk of passive smoking, allowed to use even in no-smoking places, varying nicotine levels, and availability in various flavors are some of the major driving factors for the e-cigarettes market. in addition, the increasing popularity of e-cigarettes backed by its electronic feature is the major factor contributing towards its increasing demand.
End User-Based Insights
Based on end-user, the smoking cessation aids market is segmented into hospital pharmacies, online channel, retail pharmacies, and other end users. The retail pharmacies segment is likely to hold the largest share of the market in 2021, however the online channel segment is anticipated to register the highest CAGR of the market during the forecast period.
The key players such as Pfizer Inc.; GlaxoSmithKline plc.; Dr. Reddy's Laboratories; Johnson and Johnson Services, Inc.; Cipla Inc.; Perrigo Company plc; Bausch Health Companies Inc.; Glenmark; NJOY; and Juul Labs adopt several organic and inorganic strategies to enhance their revenue and market standings. For instance, in July 2020, Dr Reddy’s Laboratories launched of over-the-counter Nicotine Polacrilex lozenges in the American market in the strengths of 2 mg and 4 mg. Moreover, in November 2020, Perrigo Company plc completed its the fourth year of its “Quitting is Better” campaign in partnership with the American Cancer Society (ACS).
Smoking Cessation Aids Market Report Scope
Smoking Cessation Aids Market – by Product
- Nicotine Replacement Therapy
- Drugs
- Electronic Cigarettes
- Others
Smoking Cessation Aids Market – by End User
- Hospital Pharmacies
- Online Channel
- Retail Pharmacies
- Others
Smoking Cessation Aids Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East &Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and End-User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The Smoking Cessation Aids Market majorly consists of the players such as Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc., Cipla Inc., Perrigo Company plc, Bausch Health Companies Inc., Glenmark, NJOY, Juul Labs among others amongst others.
The US is the largest market for Smoking Cessation Aids at a global level. The market's growth is attributed to the Increasing implementation of various tobacco control programs, high expenditure in healthcare and wellness by the countries in the region and launch of new and innovative products by market players for smoking cessation are some of the factors likely to drive the Smoking Cessation Aids market in the region. According to CDC, in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) currently smoke cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down.
Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the region. For instance, an international collaboration of researchers, led by those from Vanderbilt University in the United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India in Tobacco Smoking and Mortality in Asia, a pooled meta-analysis published by JAMA Network in March 2019. By 2030, it is anticipated that 8.3 million fatalities would be due to smoking. China, India, and Indonesia account for half of the world's male smokers, and Asia is the world's largest tobacco user and production.
The global Smoking Cessation Aids market based on product is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment held the largest share of the market, by product. The electronic cigarettes segment of Smoking Cessation Aids Market is also expected to witness fastest CAGR during 2021 to 2028.The increasing number of campaigns to reduce smoking and tobacco dependence are likely to increase the demand for the above-mentioned products. Therefore, it is expected that market is likely to propel during the forecast period.
The factors that are driving and restraining factors that will affect Smoking Cessation Aids Market in the coming years. Factors such as rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.
Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Smoking Cessation Aids Market – By Product
1.3.2 Global Smoking Cessation Aids Market – By End User
1.3.3 Global Smoking Cessation Aids Market – By Geography
2. Smoking Cessation Aids Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Smoking Cessation Aids Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Smoking Cessation Aids Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Addiction of Tobacco Smoking
5.1.2 Increasing Awareness Activities and Campaigns to Reduce Tobacco Usage and Dependence
5.2 Market Restraints
5.2.1 Steeping Costs for Development of Nicotine Replacement Therapies
5.3 Market Opportunities
5.3.1 E-cigarette Epidemic Among Youth
5.4 Future Trends
5.4.1 Introduction of New Smoking Cessation Aids
5.5 Impact Analysis
6. Smoking Cessation Aids Market – Global Analysis
6.1 Global Smoking Cessation Aids Market Revenue Forecast and Analysis
6.2 Global Smoking Cessation Aids Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Smoking Cessation Aids Market Analysis – By Product
7.1 Overview
7.2 Smoking Cessation Aids Market Revenue Share, by Product (2021 and 2028)
7.3 Nicotine Replacement Therapy
7.3.1 Overview
7.3.2 Nicotine Replacement Therapy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Drugs
7.4.1 Overview
7.4.2 Drugs: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Electronic Cigarettes
7.5.1 Overview
7.5.2 Electronic Cigarettes: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8. Smoking Cessation Aids Market Analysis – By End-User
8.1 Overview
8.2 Smoking Cessation Aids Market Share, by End-User, 2021 and 2028, (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Online Channel
8.4.1 Overview
8.4.2 Online Channel: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Retail Pharmacies
8.5.1 Overview
8.5.2 Retail Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Other End Users
8.6.1 Overview
8.6.2 Other End Users: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
9. Smoking Cessation Aids Market – Geographic Analysis
9.1 North America: Smoking Cessation Aids Market
9.1.1 Overview
9.1.2 North America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.3 North America: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.4 North America: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.5 North America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Smoking Cessation Aids Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 US: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2 US: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.5.1.3 US: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.5.2 Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2 Canada: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.5.2.3 Canada: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.5.3 Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2 Mexico: Smoking Cessation Aids Market, by Product – 2019–2028 (USD Million)
9.1.5.3.3 Mexico: Smoking Cessation Aids Market, by End User – 2019–2028 (USD Million)
9.2 Europe: Smoking Cessation Aids Market
9.2.1 Overview
9.2.2 Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.2.4 Europe: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.2.5 Europe: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.1.1 Germany: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.1.2 Germany: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.2.5.1.3 Germany: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.2.5.2 France: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.2.1 France: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.2.2 France: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.2.5.2.3 France: Smoking Cessation Aids Market, End User– 2019–2028 (USD Million)
9.2.5.3 UK: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.1 UK: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.2 UK: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.2.5.3.3 UK: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.2.5.4 Italy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.1 Italy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.2 Italy: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.2.5.4.3 Italy: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.2.5.5 Spain: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.1 Spain: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.2 Spain: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.2.5.5.3 Spain: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.2.5.6 Rest of Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.1 Rest of Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.2 Rest of Europe: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.2.5.6.3 Rest of Europe: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1 Asia Pacific: Smoking Cessation Aids Market
9.1.1 Overview
9.1.2 Asia Pacific: Smoking Cessation Aids Market - Revenue and Forecast to 2028 (USD Million)
9.1.3 Asia Pacific: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.4 Asia Pacific: Smoking Cessation Aids Market, by End-User, 2019–2028 (USD Million)
9.1.5 Asia Pacific: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
9.1.6 China: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 China: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 China: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.6.3 China: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.7 Japan: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Japan: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Japan: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.7.3 Japan: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.8 India: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 India: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 India: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.8.3 India: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.9 Australia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.9.1 Australia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.9.2 Australia: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.9.3 Australia: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.10 South Korea: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.10.1 South Korea: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.10.2 South Korea: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.10.3 South Korea: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.11 Rest of Asia Pacific: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.11.1 Rest of Asia Pacific: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.11.2 Rest of Asia Pacific: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.11.3 Rest of Asia Pacific: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.2 Middle East & Africa: Smoking Cessation Aids Market
9.2.1 Overview
9.2.2 Middle East & Africa: Smoking Cessation Aids Market - Revenue and Forecast to 2028 (US$ Million)
9.2.3 Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
9.2.4 Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
9.2.5 Middle East & Africa: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
9.2.6 Saudi Arabia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.1 Saudi Arabia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.2 Saudi Arabia Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
9.2.6.3 Saudi Arabia Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
9.2.7 UAE: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.1 UAE: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.2 UAE Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
9.2.7.3 UAE Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
9.2.8 South Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.1 South Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.2 South Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
9.2.8.3 South Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
9.2.9 Rest of Middle East and Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.1 Rest of Middle East and Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.2 Rest of Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
9.2.9.3 Rest of Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
9.3 South and Central America: Smoking Cessation Aids Market
9.3.1 Overview
9.3.2 South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.3.3 South and Central America: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.3.4 South and Central America: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.3.5 South and Central America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
9.3.5.1 Brazil: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.1.1 Brazil: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.1.2 Brazil: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.3.5.1.3 Brazil: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.3.5.2 Argentina: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.2.1 Argentina: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.2.2 Argentina: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.3.5.2.3 Argentina: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
9.3.5.3 Rest of South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.3.1 Rest of South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.3.2 Rest of South and Central America: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.3.5.3.3 Rest of South and Central America: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on Global Smoking Cessation Aids Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Pfizer Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Dr. Reddy's Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Johnson and Johnson Services, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cipla Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Perrigo Company plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Glenmark
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NJOY
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Juul Labs
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Countries with Highest Number of Smokers Worldwide in 2021
Table 2. North America Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Smoking Cessation Aids Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 4. US Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 5. US: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Europe: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 11. Europe: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Germany: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 13. Germany: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 14. France: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 15. France: Smoking Cessation Aids Market, End User– Revenue and Forecast to 2028 (USD Million)
Table 16. UK: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 17. UK: Smoking Cessation Aids Market, End User– Revenue and Forecast to 2028 (USD Million)
Table 18. Italy: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 24. Asia Pacific: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 25. Asia Pacific Smoking Cessation Aids Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 26. China: Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 27. China: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 28. Japan: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 29. Japan: Smoking Cessation Aids Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 30. India: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 31. India: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 32. Australia: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 33. Australia: Smoking Cessation Aids Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 34. South Korea: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 35. South Korea: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of Asia Pacific: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 38. Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 39. Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
Table 40. Saudi Arabia Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 41. Saudi Arabia Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
Table 42. UAE Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 43. UAE Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
Table 44. South Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 45. South Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
Table 46. Rest of Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 47. Rest of Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)
Table 48. South and Central America: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 49. South and Central America: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 50. Brazil: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 51. Brazil: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 52. Argentina: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 53. Argentina: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of South and Central America: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of South and Central America: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 56. Organic Developments Done By Companies
Table 57. Inorganic Developments Done By Companies
Table 58. Glossary of Terms, Smoking Cessation Aids Market
LIST OF FIGURES
Figure 1. Smoking Cessation Aids Market Segmentation
Figure 2. Smoking Cessation Aids Market Segmentation, By Region
Figure 3. Smoking Cessation Aids Market Overview
Figure 4. Electronic Cigarettes Segment Held Largest Share of Smoking Cessation Aids Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Smoking Cessation Aids Market, by Geography (US$ Million)
Figure 7. Global Smoking Cessation Aids Market – Leading Country Markets (US$ Million)
Figure 8. Global Smoking Cessation Aids Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Smoking Cessation Aids Market Impact Analysis of Drivers and Restraints
Figure 15. Global Smoking Cessation Aids Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Smoking Cessation Aids Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Smoking Cessation Aids Market
Figure 18. Smoking Cessation Aids Market Revenue Share, by Product (2021 and 2028)
Figure 19. Nicotine Replacement Therapy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Drugs: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Electronic Cigarettes: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Smoking Cessation Aids Market Share, by End-User, 2021 and 2028 (%)
Figure 24. Hospital Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Online Channel: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Retail Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other End Users: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)
Figure 30. North America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
Figure 31. US: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Europe: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)
Figure 35. Europe: Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)
Figure 36. Europe: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
Figure 37. Germany: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. France: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. UK: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Italy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Spain: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Rest of Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Asia Pacific: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)
Figure 44. Asia Pacific Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)
Figure 45. Asia Pacific: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
Figure 46. China: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Japan: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. India: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Australia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. South Korea: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Rest of Asia Pacific: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. Middle East & Africa: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)
Figure 53. Middle East & Africa Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Middle East & Africa: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
Figure 55. Saudi Arabia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. UAE: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. South Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Rest of Middle East and Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. South and Central America: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)
Figure 60. South and Central America: Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)
Figure 61. South and Central America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
Figure 62. Brazil: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Argentina: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Rest of South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Impact of COVID-19 Pandemic in North American Country Markets
Figure 66. Impact of COVID-19 Pandemic in European Country Markets
Figure 67. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 68. Impact Of COVID-19 Pandemic In Middle East & Africa Market
Figure 69. Impact Of COVID-19 Pandemic In South and Central America Countries Market
Figure 70. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Smoking Cessation Aids Market
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Smoking Cessation Aids Market
Aug 2021
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Aug 2021
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Aug 2021
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Aug 2021
Electronic Patient-Reported Outcomes (ePROS) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Wellbeing Platform Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Wellbeing, and Others), Category (Fitness & Nutrition Consultant, Psychological Therapists, and Organization/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organization, and Homecare), and Geography
Aug 2021
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Get Free Sample For